@RheumNow #acr20 abs0405 RELIF ph3 rct: pts w/Behcets who achieve Full resolution of OUs w/Apremilast by wk6+ 6wks of sustained response also report better improvement in BSAS, OU pain, overall Dis activity& QoL. Only 29.8% were able to achieve 6+6 though, while 70.2% did not https://t.co/8roaO5YPM6